Department of Epidemiology, Johns Hopkins Bloomberg School of Public Health, Baltimore, MD, USA.
Department of Population Medicine, Massachusetts General Hospital, Boston, MA, USA.
Clin Chem. 2021 Jan 8;67(1):298-307. doi: 10.1093/clinchem/hvaa288.
Cardiac markers such as high-sensitivity cardiac troponin T (hs-cTnT) and N-terminal pro-B natriuretic peptide (NTproBNP) are predictors of developing acute kidney injury (AKI) during hospitalization for surgery or revascularization. However, their associations with the long-term risk of AKI in the general population are uncharacterized.
We conducted a prospective cohort study in 10 669 participants of the Atherosclerosis Risk in Communities Study (visit 4, 1996-1998, mean age, 63 years, 56% female, 22% black race) to examine the association of plasma concentrations of hs-cTnT and NTproBNP with the incident hospitalization with AKI. We used multivariable Cox regression analysis to estimate hazard ratios (HRs).
During follow-up, 1907 participants had an incident hospitalization with AKI. Participants with higher concentrations of hs-cTnT had a higher risk of hospitalization with AKI in a graded fashion (adjusted HR, 1.88 [95%CI , 1.59-2.21] for ≥14 ng/L, 1.36 [1.18-1.57] for 9-13 ng/L, and 1.16 [1.03-1.30] for 5-8 ng/L compared to <5 ng/L). The graded association was also observed for NTproBNP (HR, 2.27 [1.93-2.68] for ≥272.7 pg/mL, 1.67 [1.45-1.93] for 142.4-272.6 pg/mL, and 1.31 [1.17-1.47] for 64.0-142.3 pg/mL compared to <64.0 pg/mL). The addition of hs-cTnT and NTproBNP to a model with established predictors significantly improved 10-year risk prediction for hospitalization with AKI (Δc-statistic, 0.015 [95%CI, 0.006-0.024]).
In middle-aged to older black and white adults in the community, higher concentrations of hs-cTnT and NTproBNP were robustly associated with an increased risk of hospitalization with AKI. These results suggest the usefulness of hs-cTnT and NT-proBNP to identify people at risk of AKI in the general population.
高敏心肌肌钙蛋白 T(hs-cTnT)和 N 末端 pro-B 型利钠肽(NTproBNP)等心脏标志物可预测手术或血运重建住院期间急性肾损伤(AKI)的发生。然而,它们与一般人群中 AKI 的长期风险的相关性尚未明确。
我们在社区动脉粥样硬化风险研究(访问 4,1996-1998 年,平均年龄 63 岁,56%为女性,22%为黑种人)的 10669 名参与者中进行了一项前瞻性队列研究,以检验 hs-cTnT 和 NTproBNP 血浆浓度与 AKI 住院事件的相关性。我们使用多变量 Cox 回归分析来估计风险比(HRs)。
在随访期间,1907 名参与者发生 AKI 住院事件。hs-cTnT 浓度较高的参与者 AKI 住院风险呈梯度升高(校正 HR,≥14ng/L 为 1.88[95%CI,1.59-2.21],9-13ng/L 为 1.36[1.18-1.57],5-8ng/L 为 1.16[1.03-1.30],<5ng/L 为 1.00)。NTproBNP 也观察到了类似的梯度相关性(HR,≥272.7pg/mL 为 2.27[1.93-2.68],142.4-272.6pg/mL 为 1.67[1.45-1.93],64.0-142.3pg/mL 为 1.31[1.17-1.47],<64.0pg/mL 为 1.00)。在包含既定预测因素的模型中加入 hs-cTnT 和 NTproBNP 可显著提高 AKI 住院 10 年风险预测的准确性(Δc 统计量,0.015[95%CI,0.006-0.024])。
在社区中年龄较大的黑人和白人成年人中,hs-cTnT 和 NTproBNP 浓度升高与 AKI 住院风险增加显著相关。这些结果表明 hs-cTnT 和 NT-proBNP 可用于识别一般人群中 AKI 风险人群。